What if managing diabetes didn’t always mean another shot? With the FDA’s approval of Afrezza for kids and teens, diabetes management can be easier, faster, and more flexible for everyday life. Here’s why families are so excited about this needle-free insulin option.

Most people think DKA only occurs when T1D is first diagnosed or when infusion lines fail. But you aren’t out of the woods if you have type 2 diabetes, use a patch pump, or are on MDI. DKA can happen for other reasons, and often at times when it’s least expected.

High blood sugar isn’t always the primary warning sign for DKA. A lesser-known type of DKA can happen when glucose levels are below 250 mg/dL, making it one of the easiest diabetes emergencies to miss. Here’s how to recognize the signs.

Abbott’s Libre Duo, the world’s first wearable sensor that measures both glucose and ketone levels, was recently approved in Europe. This is a major advancement that may help people catch and treat diabetic ketoacidosis (DKA) early, before it becomes a medical emergency requiring an ER visit and/or hospitalization. Ketones can rise quickly (independent of blood sugar level) during illness, missed insulin doses, pump infusion line issues, dehydration, or while taking certain medications like SGLT2 inhibitors. Currently ketones are typically checked with fingersticks or urine tests, which many people only do after symptoms start. The Libre Duo measures both glucose and ketone levels every minute. The Libre Duo’s technology was designed for integration with AID systems, and is expected to launch in parts of Europe later this year. It’s currently under FDA review in the United States.

Type 2 diabetes develops when the body becomes resistant to insulin and the insulin-producing beta cells in the pancreas are no longer able to keep up. Researchers are studying an investigational oral medication that may help improve beta cell function and blood sugar control by enhancing the body’s natural insulin response. You may qualify if you are 18–70 years old, have type 2 diabetes, are currently taking diabetes medications (including Ozempic, for some studies), and are still not at your HbA1c goal. To learn more and see if you qualify, please contact 858-274-4226.